Orphalan Announces China NMPA's Approval of Its Trientine Tetrahydrochloride Product for the Treatment of Wilson disease
Orphalan Announces China NMPA's Approval of Its Trientine Tetrahydrochloride Product for the Treatment of Wilson disease
Source: medindia.net